Ingredion (INGR) has drawn fresh attention after appointing Diego Reynoso as chief financial officer, effective October 1, 2026. The leadership change places a seasoned food and beverage finance executive at the center of the company’s capital decisions.

Ingredion’s $104.62 share price has seen a mixed pattern recently, with a 1-day share price return of 1.08% and a 30-day share price return of 2.83%. However, the 1-year total shareholder return has declined 16.76%, while the 5-year total shareholder return is 36.67%.

Spot 44 high quality undervalued stocks that, like Ingredion, combine established business models with disciplined capital allocation stories that could be setting up their next move.

Ingredion now trades at a double discount, around 16% below the average analyst target and at a much wider gap to some intrinsic value estimates, even as the share price has slipped over the past year. Is the market’s caution around this CFO transition and recent returns overdone, or is the lower valuation simply catching up with the risks investors see ahead?

Most Popular Narrative: 18.6% Overvalued

According to a widely followed Ingredion narrative by AgWiz, the current $104.62 share price sits above an estimated fair value of $88.23 that is built from detailed long range assumptions about growth, margins and future valuation multiples.

I believe the market is focused on near-term acquisition uncertainty while overlooking Ingredion's long-term transformation into a more specialty-focused ingredients company. If management successfully integrates Tate & Lyle, delivers the expected synergies, and maintains its strong ROIC and free cash flow generation, the company could deserve a meaningfully higher valuation over the next 3 to 5 years.

Read the complete narrative. Read the complete narrative.

The narrative leans heavily on a gradual shift toward higher margin specialty ingredients, steady operating margin expansion and a future earnings multiple that assumes the market rewards that mix change. If you want to see exactly how those building blocks stack together, the full narrative sets out the numbers behind that overvaluation call in black and white.

Result: Fair Value of $88.23 (OVERVALUED)

However, Ingredion’s story could change quickly if the integration of Tate & Lyle disappoints, or if the specialty mix shift stalls and weighs on margins and returns.

Another View on Ingredion’s Valuation

AgWiz’s fair value of $88.23 suggests Ingredion is 18.6% overvalued. Our DCF model points in the opposite direction. It values the stock at $222.82 per share, which is very different to the current $104.62 price and implies a large margin between market price and future cash flow estimates. Which story do you think is closer to reality?

Look into how the SWS DCF model arrives at its fair value. Look into how the SWS DCF model arrives at its fair value.

Next Steps

If this mix of opinions on Ingredion leaves you unsure, that is normal. Act promptly, review the data for yourself, and then weigh up the 4 key rewards.

Looking for more investment ideas beyond Ingredion?

If Ingredion has sharpened your focus on valuation and quality, do not stop here. Use the Simply Wall Street Screener to uncover other opportunities that fit your approach.

• Target potential upside by scanning for companies that look attractively priced on fundamentals through the 44 high quality undervalued stocks.
• Secure more reliable income streams by focusing on businesses that appear capable of supporting stronger payouts via the 12 dividend fortresses.
• Protect the downside by concentrating on companies with sturdier financial profiles using the list of solid balance sheet and fundamentals (51 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.